These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 6349413)

  • 41. Pathophysiology and Treatment of Malignant Hyperthermia.
    Gregory H; Weant KA
    Adv Emerg Nurs J; 2021 Apr-Jun 01; 43(2):102-110. PubMed ID: 33915557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure.
    Chen PL; Day YJ; Su BC; Lee PC; Chen CY
    Acta Anaesthesiol Taiwan; 2007 Sep; 45(3):189-93. PubMed ID: 17972624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant hyperthermia.
    Gronert GA
    Anesthesiology; 1980 Nov; 53(5):395-423. PubMed ID: 6999950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple-pulse stimulation and dantrolene in malignant hyperthermia.
    Quinlan JG; Wedel DJ; Iaizzo PA
    Muscle Nerve; 1990 Oct; 13(10):904-8. PubMed ID: 2233846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family.
    Steinfath M; Seranski P; Singh S; Fiege M; Wappler F; Schulte Am Esch J; Scholz J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant hyperthermia.
    Moore JL; Rice EL
    Am Fam Physician; 1992 May; 45(5):2245-51. PubMed ID: 1575119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
    Censier K; Urwyler A; Zorzato F; Treves S
    J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
    Schuster F; Johannsen S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malignant Hyperthermia.
    Kaur H; Katyal N; Yelam A; Kumar K; Srivastava H; Govindarajan R
    Mo Med; 2019; 116(2):154-159. PubMed ID: 31040503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple interacting gene products may influence susceptibility to malignant hyperthermia.
    Robinson RL; Curran JL; Ellis FR; Halsall PJ; Hall WJ; Hopkins PM; Iles DE; West SP; Shaw MA
    Ann Hum Genet; 2000 Jul; 64(Pt 4):307-20. PubMed ID: 11415515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
    Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR
    Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant hyperthermia: a review.
    Golinski M
    Plast Surg Nurs; 1995; 15(1):30-3, 58. PubMed ID: 7777624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Preoperative management of malignant hyperthermia].
    Migita T; Kawamoto M
    Masui; 2010 Sep; 59(9):1138-41. PubMed ID: 20857669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Malignant hyperthermia].
    Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM
    Rev Esp Anestesiol Reanim; 1985; 32(4):169-78. PubMed ID: 3901157
    [No Abstract]   [Full Text] [Related]  

  • 58. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients].
    Mauritz W; Hackl W; Sporn P; Steinbereithner K
    Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.